Locomotor activity as an effective measure of the severity of inflammatory arthritis in a mouse model

PLoS One. 2024 Jan 17;19(1):e0291399. doi: 10.1371/journal.pone.0291399. eCollection 2024.

Abstract

Objective: Mouse models are valuable in preclinical studies of inflammatory arthritis. However, current methods for measuring disease severity or responses to treatment are not optimal. In this study a smart cage system using multiple sensors to measure locomotor activity was evaluated in the K/BxN serum transfer model of inflammatory arthritis.

Methods: Arthritis was induced in C57BL/6 mice with injections of K/BxN serum. Clinical index and ankle thickness were measured for 14 days. Locomotor activity was measured in smart cages for 23 h periods on Days 0, 7, and 13. The same measurements were taken in mice consuming diets supplemented or not with fish oil to evaluate a preventative treatment.

Results: Initiation, peak and resolution phases of disease could be measured with the smart cages. Locomotor activity including speed, travel distance, number of active movements and rear movements were all significantly lower on Days 7-8 of illness (peak) compared to Days 0 and 13-14 (resolution) (one-way repeated measures analyses, p<0.05). The clinical index and ankle thickness measurements did not capture differences between dietary groups. Significantly increased activity was measured in most of the locomotor parameters in the fish oil group compared to the control mice at both Days 8 and 14 (2-way repeated measures ANOVA, p<0.05).

Conclusion: The measurement of locomotor activity provided a more detailed evaluation of the impact of inflammatory arthritis on animal well-being and mobility than that provided by measuring clinical index and ankle thickness, and could be a valuable tool in preclinical studies of inflammatory arthritis.

MeSH terms

  • Animals
  • Arthritis*
  • Arthritis, Experimental*
  • Disease Models, Animal
  • Fish Oils / pharmacology
  • Locomotion
  • Mice
  • Mice, Inbred C57BL

Substances

  • Fish Oils

Grants and funding

MES and LHB were support by a grant from the Canadian Institutes of Health Research (#165965), https://cihr-irsc.gc.ca. LHB was supported by a grant from the Natural Sciences and Engineering Research Council of Canada (RGPIN-2019-05740), https://www.nserc-crsng.gc.ca. MES (RAI2020-002) and LHB (RAI2021-29 and RPI-99) werw supported by grants from the New Brunswick Innovation Foundation, https://nbif.ca. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.